Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-24-009512
Filing Date
2024-03-11
Accepted
2024-03-11 12:35:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 486090
2 form424b5_001.jpg GRAPHIC 11685
3 form424b5_002.jpg GRAPHIC 2805
  Complete submission text file 0001493152-24-009512.txt   507515
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-257690 | Film No.: 24737234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)